A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 45
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : lcSSc
Long Form : limited cutaneous systemic sclerosis
No. Year Title Co-occurring Abbreviation
2020 A case report, a case who developed limited cutaneous scleroderma and pulmonary hypertension 8 years after diagnosis of anti-centromere antibody-positive Sjogren syndrome. ACA, PAH, pSS
2020 Cultural adaptation, translation and validation of Cochin Hand Function Scale and evaluation of hand dysfunction in systemic sclerosis. I-CHFS
2020 Limited cutaneous systemic sclerosis with gangrene: an autopsy case. LLUs
2020 Outcomes of limited cutaneous systemic sclerosis patients: Results on more than 12,000 patients from the EUSTAR database. dcSSc, DU, mRSS
2019 Abnormalities in endothelial form of nitric oxide synthase is pathogenic in limited cutaneous systemic sclerosis. DEGs, eNOS, PPI, TFs
2019 Characteristics of patients with systemic sclerosis living in Qatar. ACA, ACR, ANA, dcSSc
2019 Correlation between circulating fibrocytes and dermal thickness in limited cutaneous systemic sclerosis patients: a pilot study. DT, mRSS, PBMCs, US
2019 Exploring the microcirculatory effects of an exercise programme including aerobic and resistance training in people with limited cutaneous systemic sclerosis. HIIT, RT
2018 A noninvasive surface wave technique for measuring finger's skin stiffness. CSWE, mRSS, USWE
10  2018 Anti-RNA polymerase III antibody-associated scleroderma renal crisis in a patient with limited cutaneous systemic sclerosis: A case report. ACE, dcSSc, RNAP, SRC
11  2018 Overlap syndromes in systemic sclerosis. ACR, CTDs, dcSSc, OS, SSc
12  2018 Prognostic profile of systemic sclerosis: analysis of the clinical EUSTAR cohort in China. CRDC, EUSTAR, ILD, MTX, PAH, PUMCH, SSc, TwHF
13  2017 Proteomic Investigation of Dermal Fibroblasts Isolated from Affected and Unaffected Skin Samples from Patients with Limited Cutaneous Systemic Sclerosis: 2 Distinct Entities? IHC, qRT-PCR, VIM
14  2017 Subclinical dermal involvement is detectable by high frequency ultrasound even in patients with limited cutaneous systemic sclerosis. DT, mRSS, US
15  2015 A cross-sectional study of autoantibody profiles in the Waikato systemic sclerosis cohort, New Zealand. dcSSc, OLS
16  2015 High-resolution ultrasound of peripheral nerves in systemic sclerosis: a pilot study of computer-aided quantitative assessment of nerve density. US
17  2015 Increased Serum Levels of the IL-33 Neutralizing sST2 in Limited Cutaneous Systemic Sclerosis. dcSSc, EC, sST2
18  2015 Thinking outside the box--The associations with cutaneous involvement and autoantibody status in systemic sclerosis are not always what we expect. CSRG, dcSSc
19  2015 [A retrospective clinical analysis of 16 patients with scleroderma renal crisis]. ACAs, ACEI, dcSSc, SRC, SSc
20  2014 Pulsed versus continuous wave low-level light therapy on osteoarticular signs and symptoms in limited scleroderma (CREST syndrome): a case report. CW, LLLT
21  2014 Systemic sclerosis sine scleroderma and limited cutaneous systemic sclerosis: similarities and differences. PAH, ssSSc
22  2013 Increased expression of endoplasmic reticulum stress and unfolded protein response genes in peripheral blood mononuclear cells from patients with limited cutaneous systemic sclerosis and pulmonary arterial hypertension. ATF4, ER, HSPs, IFN, PAH, PBMCs, UPR
23  2013 [A case of neuromyelitis optica spectrum disorder associated with a limited cutaneous systemic sclerosis and Sjogren syndrome]. NMOSD
24  2012 High-resolution computed tomographic findings in systemic sclerosis-associated interstitial lung disease: comparison between diffuse and limited systemic sclerosis. AD, dcSSc, HRCT, MPAD/AD, WED
25  2012 Progression of esophageal dysmotility in systemic sclerosis. dcSSc, ED, ETS
26  2011 Antinuclear antibodies and clinical associations in a british cohort with limited cutaneous systemic sclerosis. ANA
27  2011 Hearing loss in diffuse cutaneous systemic scleroderma. ACR, dcSSc, PISR
28  2011 Histopathological cutaneous alterations in systemic sclerosis: a clinicopathological study. dcSSc, lSSc, SSc
29  2011 Historical perspectives on the discovery and elucidation of autoantibodies to centromere proteins (CENP) and the emerging importance of antibodies to CENP-F. CENP, CREST, IIF
30  2011 Modified-release sildenafil reduces Raynaud's phenomenon attack frequency in limited cutaneous systemic sclerosis. PAT, RP
31  2010 Acute right heart failure and achalasia-like syndrome in a patient with limited cutaneous systemic sclerosis and primary biliary cirrhosis. ---
32  2009 Naturally occurring and disease-associated auto-antibodies against topoisomerase I: a fine epitope mapping study in systemic sclerosis and systemic lupus erythematosus. aa, dcSSc, SLE, SSc, topo I
33  2008 Association of increased telomere lengths in limited scleroderma, with a lack of age-related telomere erosion. PBL
34  2007 Carotid thrombus formation and extension during anticoagulation: a case report of large vessel disease and hypercoagulable state in systemic sclerosis. dsSSc, SSc
35  2007 Prevention of vascular damage in scleroderma and autoimmune Raynaud's phenomenon: a multicenter, randomized, double-blind, placebo-controlled trial of the angiotensin-converting enzyme inhibitor quinapril. RP
36  2007 Role of the interferon-inducible gene IFI16 in the etiopathogenesis of systemic autoimmune disorders. dcSSc, IFNs, SLE, SSc
37  2006 Different clinical features in patients with limited and diffuse cutaneous systemic sclerosis. dcSSc, DLCO, FVC
38  2006 Influence of clinical features on the health status of patients with limited cutaneous systemic sclerosis. MCS, PCS, VAS
39  2005 Computerized nailfold video capillaroscopy--a new tool for assessment of Raynaud's phenomenon. dcSSc, RP
40  2005 Lipoprotein profile in limited systemic sclerosis. ACA, HDL, NCEP, PH
41  2005 [Efficacy of anti-thymocyte globulin and cyclosporin A combined therapy in aplastic anemia complicated with limited cutaneous systemic sclerosis]. ---
42  2003 A comparison between anti-Th/To- and anticentromere antibody-positive systemic sclerosis patients with limited cutaneous involvement. ACA
43  2003 Treatment of cutaneous calcinosis in limited systemic sclerosis with minocycline. ANA
44  2002 Digital vascular response to topical glyceryl trinitrate, as measured by laser Doppler imaging, in primary Raynaud's phenomenon and systemic sclerosis. GTN, PRP
45  2001 Serum TIMP-1, TIMP-2, and MMP-1 in patients with systemic sclerosis, primary Raynaud's phenomenon, and in normal controls. dcSSc, ELISAs, MMP-1, MMPs, RP, SSc, TIMPs